Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9529)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2021 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mitrofanova A, Burke G, Merscher S, Fornoni A. New insights into renal lipid dysmetabolism in diabetic kidney disease. World J Diabetes 2021; 12(5): 524-540 [PMID: 33995842 DOI: 10.4239/wjd.v12.i5.524] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i5/524.htm |
| Number | Citing Articles |
| 1 |
Rachel Njeim, Sahar Alkhansa, Alessia Fornoni. Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease. Pharmaceutics 2023; 15(5): 1360 doi: 10.3390/pharmaceutics15051360
|
| 2 |
Mohammed M. Elseweidy, Mervat E. Asker, Reham R. El-Zeiky, Asmaa M. Elmaghraby, Rania A. Elrashidy. Sitagliptin alleviates renal steatosis and endoplasmic reticulum stress in high fat diet-induced obese rats by targeting SREBP-1/CD36 signaling pathway. European Journal of Pharmacology 2024; 977: 176745 doi: 10.1016/j.ejphar.2024.176745
|
| 3 |
Yiran Zhang, Hai-Long Piao, Di Chen. Identification of Spatial Specific Lipid Metabolic Signatures in Long-Standing Diabetic Kidney Disease. Metabolites 2024; 14(11): 641 doi: 10.3390/metabo14110641
|
| 4 |
Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang. Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy. Integrative Medicine in Nephrology and Andrology 2024; 11(4) doi: 10.1097/IMNA-D-23-00029
|
| 5 |
Ziwei Zhang, Yuting Sun, Jiaojiao Xue, De Jin, Xiangyan Li, Daqing Zhao, Fengmei Lian, Wenxiu Qi, Xiaolin Tong. The critical role of dysregulated autophagy in the progression of diabetic kidney disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.977410
|
| 6 |
Halimat Amin Abdulrahim, Adeyemi Fatai Odetayo, Adeoye Tunwagun David, Yusuf Funsho Abdulquadri, Rofiat Oluwasheun Sheu, Pelumi Kikelomo Oluwafemi, Kazeem Bidemi Okesina, Luqman Aribidesi Olayaki. Physical exercise improved the hematological effect of vitamin D in type 2 diabetes mellitus-induced nephrotoxicity in rats. Biochemistry and Biophysics Reports 2024; 40: 101839 doi: 10.1016/j.bbrep.2024.101839
|
| 7 |
Jin-Lei Wang, Jia-Ping Yan, Xiang Li, Md Shahidul Islam, Jian-Bo Xiao, Lu Cai, Na Ma, Li Ma, Lian-Sheng Ma. Meeting report of the chief editorial board meeting for <i>World Journal of Diabetes </i>2021. World Journal of Diabetes 2021; 12(12): 1969-1978 doi: 10.4239/wjd.v12.i12.1969
|
| 8 |
菊丽 曾. The Predicted Role of MIOX Expression in the Early Diabetic Renal Damage. Advances in Clinical Medicine 2022; 12(12): 12206 doi: 10.12677/ACM.2022.12121758
|
| 9 |
Cornel Manuel Bachmann, Daniel Janitschke, Anna Andrea Lauer, Tobias Erhardt, Tobias Hartmann, Marcus Otto Walter Grimm, Heike Sabine Grimm. Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells. International Journal of Molecular Sciences 2023; 24(3): 2972 doi: 10.3390/ijms24032972
|
| 10 |
Lili Song, Rui Han, Hongqing Yin, Jingfang Li, Yue Zhang, Jiayi Wang, Zhen Yang, Junwei Bai, Maojuan Guo. Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy. Metabolomics 2022; 18(6) doi: 10.1007/s11306-022-01879-7
|
| 11 |
Shaokang Pan, Zhengyong Li, Yixue Wang, Lulu Liang, Fengxun Liu, Yingjin Qiao, Dongwei Liu, Zhangsuo Liu. A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease. Journal of Translational Internal Medicine 2023; 10(4): 359 doi: 10.2478/jtim-2022-0053
|
| 12 |
Tingting Zhao, Qian Xiang, Beifeng Lie, Deqi Chen, Minyi Li, Xi Zhang, Junzheng Yang, Bao He, Wei Zhang, Ruixue Dong, Yadi Liu, Junling Gu, Quan Zhu, Yijing Yao, Tingting Duan, Zhenghai Li, Youhua Xu. Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways. Heliyon 2023; 9(3): e14171 doi: 10.1016/j.heliyon.2023.e14171
|
| 13 |
Irena Audzeyenka, Agnieszka Bierżyńska, Abigail C Lay. Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria. Endocrinology 2022; 163(1) doi: 10.1210/endocr/bqab234
|
| 14 |
Pavlína Piťhová, Michaela Cichrová, Milan Kvapil, Jaroslav A. Hubáček, Dana Dlouhá, Jan Piťha. Determinants of vascular impairment in type 1 diabetes–impact of sex and connexin 37 gene polymorphism: A cross-sectional study. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02401-0
|
| 15 |
Hua Wang, Shu Zhang, Jia Guo. Lipotoxic Proximal Tubular Injury: A Primary Event in Diabetic Kidney Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.751529
|
| 16 |
Roberto Boi, Kerstin Ebefors, Marcus Henricsson, Jan Borén, Jenny Nyström. Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10907-4
|
| 17 |
A cross-sectional study to correlate antioxidant enzymes, oxidative stress and inflammation with prevalence of hypertension. Life Sciences 2023; 313: 121134 doi: 10.1016/j.lfs.2022.121134
|
| 18 |
Yi-Qi Yang, Hai-Bo Tan, Xiao-Yu Zhang, Yu-Zhen Zhang, Quan-You Lin, Min-Yi Huang, Zi-Yang Lin, Jia-Zhi Mo, Yue Zhang, Tian Lan, Wei-Jian Bei, Jiao Guo. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease. Journal of Ethnopharmacology 2022; 292: 115165 doi: 10.1016/j.jep.2022.115165
|
| 19 |
Yi-Zhen Han, Bo-Xuan Du, Xing-Yu Zhu, Yang-Zhi-Yuan Wang, Hui-Juan Zheng, Wei-Jing Liu. Lipid metabolism disorder in diabetic kidney disease. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1336402
|
| 20 |
Bei Xu, Wanyi Li, Yamei Zhang, Yan Chen, Jiafu Feng, Xiangrong Song. Untargeted and spatial-resolved metabolomics characterize serum and tissue-specific metabolic reprogramming in acute kidney injury. Heliyon 2023; 9(11): e21171 doi: 10.1016/j.heliyon.2023.e21171
|
| 21 |
Xin Chen, Shenglong Zhu, Ciyou Huang, Jiayi Liu, Jinbang Wang, Siyuan Cui. Bioinformatic analyses reveal lysosomal-associated protein transmembrane 5 as a potential therapeutic target in lipotoxicity-induced injury in diabetic kidney disease. Renal Failure 2024; 46(2) doi: 10.1080/0886022X.2024.2359638
|
| 22 |
T. T. Podvigina, N. I. Yarushkina, L. P. Filaretova. Effects of Running on the Development of Diabetes and Diabetes-Induced Complications. Journal of Evolutionary Biochemistry and Physiology 2022; 58(1): 174 doi: 10.1134/S0022093022010161
|
| 23 |
Ishant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, Sørine Birkelund, Anna Syreeni, Carol Forsblom, Jun Okabe, Mark Ziemann, Antony Kaspi, Haloom Rafehi, Anne Jørgensen, Keith Al-Hasani, Merlin C. Thomas, Guozhi Jiang, Andrea O.Y. Luk, Heung Man Lee, Yu Huang, Yotsapon Thewjitcharoen, Soontaree Nakasatien, Thep Himathongkam, Christopher Fogarty, Rachel Njeim, Assaad Eid, Tine Willum Hansen, Nete Tofte, Evy C. Ottesen, Ronald C.W. Ma, Juliana C.N. Chan, Mark E. Cooper, Peter Rossing, Per-Henrik Groop, Assam El-Osta. Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes . Journal of Clinical Investigation 2023; 133(4) doi: 10.1172/JCI160959
|
| 24 |
Ahmed O. Elzoghby, Omar Samir, Ahmed Soliman, Sergey Solomevich, Minzhi Yu, Anna Schwendeman, Mahmoud L. Nasr. Nanodiscs: Game changer nano-therapeutics and structural biology tools. Nano Today 2023; 53: 102026 doi: 10.1016/j.nantod.2023.102026
|
| 25 |
Sinan Ai, Yake Li, Huijuan Zheng, Zhen Wang, Weijing Liu, JiaYin Tao, Yaotan Li, Yaoxian Wang. Global research trends and hot spots on autophagy and kidney diseases: a bibliometric analysis from 2000 to 2022. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1275792
|
| 26 |
Shu Ye, Ye-peng Hu, Qiao Zhou, Hang Zhang, Zhe-zheng Xia, Shu-zhen Zhao, Zhe Wang, Sheng-yao Wang, Xin-yi Wang, Yi-kai Zhang, Zhi-da Chen, Guang-yun Mao, Chao Zheng. Lipidomics Profiling Reveals Serum Phospholipids Associated with Albuminuria in Early Type 2 Diabetic Kidney Disease. ACS Omega 2023; 8(39): 36543 doi: 10.1021/acsomega.3c05504
|
| 27 |
Shaokang Pan, Zhengyong Li, Yixue Wang, Lulu Liang, Fengxun Liu, Yingjin Qiao, Dongwei Liu, Zhangsuo Liu. A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease. Journal of Translational Internal Medicine 2023; 10(4): 359 doi: 10.2478/jtim-2022-0053
|
| 28 |
Ying Chen, Rong Rui, Li Wang, Hao Wang, Bingbing Zhu, Aili Cao. Huangqi decoction ameliorates kidney injury in db/db mice by regulating the BMP/Smad signaling pathway. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04029-1
|
| 29 |
Kaihui Zhang, Peng Peng, Jinhao Huang, Ming Chen, Fangle Liu, Chenchen Zhu, Qifu Lu, Meiqi Wang, Chaozhan Lin. Integrating plasma metabolomics and gut microbiome to reveal the mechanisms of Huangqi Guizhi Wuwu Decoction intervene diabetic peripheral neuropathy. Journal of Ethnopharmacology 2024; 319: 117301 doi: 10.1016/j.jep.2023.117301
|
| 30 |
Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Lin. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. International Journal of Molecular Sciences 2021; 22(13): 6680 doi: 10.3390/ijms22136680
|
| 31 |
Tian Gan, Qingzhu Wang, Yi Song, Mingwei Shao, Yanyan Zhao, Feng Guo, Fangyi Wei, Xunjie Fan, Wei Zhang, Yuanyuan Luo, Duo Chen, Shanshan Wang, Guijun Qin. Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease. Molecular and Cellular Endocrinology 2024; 582: 112139 doi: 10.1016/j.mce.2023.112139
|
| 32 |
Xiaoting Fan, Meilin Yang, Yating Lang, Shangwei Lu, Zhijuan Kong, Ying Gao, Ning Shen, Dongdong Zhang, Zhimei Lv. Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death & Disease 2024; 15(6) doi: 10.1038/s41419-024-06833-0
|
| 33 |
Marissa J. DeFreitas, Chryso P. Katsoufis, Merline Benny, Karen Young, Shathiyah Kulandavelu, Hyunyoung Ahn, Anna Sfakianaki, Carolyn L. Abitbol. Educational Review: The Impact of Perinatal Oxidative Stress on the Developing Kidney. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.853722
|
| 34 |
Kamila Misiakiewicz-Has, Dominika Maciejewska-Markiewicz, Dagmara Szypulska-Koziarska, Agnieszka Kolasa, Barbara Wiszniewska. The Influence of Soy Isoflavones and Soy Isoflavones with Inulin on Kidney Morphology, Fatty Acids, and Associated Parameters in Rats with and without Induced Diabetes Type 2. International Journal of Molecular Sciences 2024; 25(10): 5418 doi: 10.3390/ijms25105418
|
| 35 |
Meghan E. Pauley, Carissa Vinovskis, Alexis MacDonald, Madison Baca, Laura Pyle, R. Paul Wadwa, Alessia Fornoni, Kristen J. Nadeau, Meda Pavkov, Robert G. Nelson, Daniel Gordin, Ian H. de Boer, Kalie L. Tommerdahl, Petter Bjornstad. Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes. Journal of Diabetes and its Complications 2023; 37(2): 108384 doi: 10.1016/j.jdiacomp.2022.108384
|
| 36 |
Rachel Njeim, Sandra Merscher, Alessia Fornoni. Mechanisms and implications of podocyte autophagy in chronic kidney disease. American Journal of Physiology-Renal Physiology 2024; 326(6): F877 doi: 10.1152/ajprenal.00415.2023
|
| 37 |
Weijing Lai, Min Shi, Rongshuang Huang, Ping Fu, Liang Ma. Fatty acid-binding protein 4 in kidney diseases: From mechanisms to clinics. European Journal of Pharmacology 2022; 931: 175224 doi: 10.1016/j.ejphar.2022.175224
|
| 38 |
Chuanping Zhao, Jiamei Tang, Xiaoya Li, Zihan Yan, Liangliang Zhao, Wenbo Lang, Chunmao Yuan, Chengyan Zhou. Beneficial effects of procyanidin B2 on adriamycin-induced nephrotic syndrome mice: the multi-action mechanism for ameliorating glomerular permselectivity injury. Food & Function 2022; 13(16): 8436 doi: 10.1039/D1FO03616E
|
| 39 |
Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Yuancheng Zhao, Huan Xu, Lin Li, Nanwei Tong, Fang Liu. Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study. Acta Diabetologica 2022; 60(2): 225 doi: 10.1007/s00592-022-01978-w
|
| 40 |
Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad. Targeting DNA methylation in diabetic kidney disease: A new perspective. Life Sciences 2023; 335: 122256 doi: 10.1016/j.lfs.2023.122256
|
| 41 |
Ankita Beniwal, Jasmine Chaudhary Jain, Akash Jain. Lipids: A Major Culprit in Diabetic Nephropathy. Current Diabetes Reviews 2024; 20(8) doi: 10.2174/0115733998259273231101052549
|
| 42 |
Lidan Hu, Zhaoyang Peng, Guannan Bai, Haidong Fu, Danny Junyi Tan, Jingjing Wang, Wei Li, Zhongkai Cao, Guoping Huang, Fei Liu, Yi Xie, Li Lin, Jingmiao Sun, Langping Gao, Yixuan Chen, Ruihan Zhu, Jianhua Mao. Lipidomic profiles in serum and urine in children with steroid sensitive nephrotic syndrome. Clinica Chimica Acta 2024; 555: 117804 doi: 10.1016/j.cca.2024.117804
|
| 43 |
Seung Yun Chae, Yaeni Kim, Cheol Whee Park. Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia. Antioxidants 2023; 12(12): 2083 doi: 10.3390/antiox12122083
|
| 44 |
Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi. Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus. Renal Failure 2023; 45(1) doi: 10.1080/0886022X.2023.2215880
|
| 45 |
Jozaa Z. AlTamimi, Nora A. AlFaris, Ghedeir M. Alshammari, Reham I. Alagal, Dalal H. Aljabryn, Mohammed Abdo Yahya. Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2. Saudi Pharmaceutical Journal 2023; 31(11): 101817 doi: 10.1016/j.jsps.2023.101817
|
| 46 |
Rong Qi, Shao-san Kang, Yongchao Pei, Mingming Liu, Yufan Zhou, Bo Guan, Xinduo Zhang, Zhiguo Li, Fenghong Cao. LC-MS-based untargeted metabolomics reveals the mechanism underlying prostate damage in a type 2 diabetes mouse model. Reproductive Biology 2023; 23(4): 100811 doi: 10.1016/j.repbio.2023.100811
|
| 47 |
Hongtu Hu, Wei Liang, Zongwei Zhang, Zikang Liu, Fan Chu, Yan Bao, Jialu Ran, Guohua Ding, Christian S. Goebl. The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease. International Journal of Endocrinology 2022; 2022: 1 doi: 10.1155/2022/2550744
|
| 48 |
Yuanyuan Zhang, Zheng Zhang, Lili Huang, Chunxia Wang, Pengfei Yang, Ling Zhang, Xiaohui Liao. Augmenter of liver regeneration knockout aggravates tubular ferroptosis and macrophage activation by regulating carnitine palmitoyltransferase‐1A‐induced lipid metabolism in diabetic nephropathy. Acta Physiologica 2024; 240(7) doi: 10.1111/apha.14159
|